China Looms Large Seeking New Funding, Deals At J.P. Morgan

Chinese biotech companies are raising their profile and increasing their appeals to investors and partners at the J.P. Morgan Healthcare Conference. After billions in investment and increased activity in M&As, China is likely to remain attractive for international companies large and small vying for a slice of investment or pursuing innovative therapies.

train fast run on railway track in sunny day

At this week's J.P. Morgan Healthcare Conference, roughly 3,000 delegates from China are estimated to have descended into San Francisco, in large part to scout for deals and partnerships.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia